An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis.
Arvin A, Campadelli-Fiume G, Mocarski E, et al., editors.
Cambridge: Cambridge University Press; 2007.
Table of contents
Chapter 44, Persistence in the population: epidemiology and transmisson.
Boppana SB, Fowler KB.
Chapter 38, VZV: molecular basis of persistence (latency and reactivation).
Cohen JI.
Chapter 61, EBV and KSHV – related herpesviruses in non-human primates.
Blossom D.
Chapter 27, EBV gene expression and regulation.
Young LS, Arrand JR, Murray PG.
Chapter 37, VZV: pathogenesis and the disease consequences of primary infection.
Moffat J, Ku CC, Zerboni L, et al.
Chapter 29, Effects on apoptosis, cell cycle and transformation, and comparative aspects of EBV with other known DNA tumor viruses.
Klein G, Ernberg I.
Chapter 70, Varicella-zoster vaccine.
Gershon AA.
Chapter 24, Maintenance and replication during latency.
Lieberman PM, Hu J, Renne R.
Chapter 74, Adoptive immunotherapy for herpesviruses.
Leen AM, Sili U, Bollard CM, et al.
Chapter 22, Introduction to the human γ-herpesviruses.
Longnecker R, Neipel F.
Chapter 53, The epidemiology of EBV and its association with malignant disease.
Hjalgrim H, Friborg J, Melbye M.
Chapter 66, Antiviral therapy for human cytomegalovirus.
Griffiths PD, Boeckh M.
Chapter 26, Reactivation and lytic replication of KSHV.
Lukac DM, Yuan Y.
Chapter 34, Immunobiology and host response.
Koelle DM.
Chapter 48, HHV-6A, 6B, and 7: immunobiology and host response.
Wang FZ, Pellett PE.
Chapter 32, Pathogenesis and disease.
Whitley R, Kimberlin DW, Prober CG.
Chapter 25, Reactivation and lytic replication of EBV.
Kenney SC.
Chapter 64, Antiviral therapy of HSV-1 and -2.
Kimberlin DW, Whitley RJ.
Chapter 31, Human gammaherpesvirus immune evasion strategies.
Means RE, Lang SM, Jung JU.
Chapter 63, Subversion of innate and adaptive immunity: immune evasion from antibody and complement.
Hook LM, Friedman HM.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on